JB Chemicals & Pharmaceuticals Limited

NSE: JBCHEPHARM · Healthcare

Overview

JB Chemicals & Pharmaceuticals Limited Share Price & Analysis

₹2,416.1▲ +0.30%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹2,416.1
+0.3%
Open
₹—
High
₹2,525.5
Low
₹2,380
Close
₹2,416.1
52W High
₹2,526
52W Low
₹1,603
Volume
4779K
Lot Size
1
Sector
Healthcare
Market Cap
₹39K Cr
Face Value
₹1
Large CapNIFTY 500

Price Chart

Fundamentals

P/E
53.8
Sector P/E
54.4
P/B
8.22
EPS
₹44.52
ROE
18.9%
ROCE
25.4%
D/E Ratio
0
Div Yield
0.91%
Book Value
₹259
+

Strengths

  • ✓Strong return on equity (ROE 18.9%)
  • ✓Efficient capital deployment (ROCE 25.4%)
  • ✓Virtually debt-free
−

Concerns

  • ✗High premium to book value (P/B 8.2x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
₹7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
₹1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
₹2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

JBCHEPHARM · as of Mar 2026

Promoters47.84%▼5.82
FII18.30%▲3.66
DII18.71%▲2.31
Public15.13%▼0.16
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters53.83%53.78%53.77%53.74%53.66%47.84%
FII10.35%11.06%12.17%13.63%14.64%18.30%
DII18.53%18.38%17.61%16.81%16.40%18.71%
Public17.27%16.78%16.42%15.80%15.29%15.13%
Govt—0.01%—0.01%——

Corporate Events

Merger

Event16 Jul 2026

Dividend - Rs 9.30 Per Share

Dividend28 May 2026

Interim Dividend - Rs 12.70 Per Share

Dividend10 Feb 2026

Dividend - Rs 7 Per Share

Dividend29 Jul 2025

Interim Dividend - Rs 8.50 Per Share

Record: 7 Feb 2025

Dividend6 Feb 2025

Dividend - Rs 6.75 Per Share

Dividend13 Aug 2024

Interim Dividend - Rs 5.50 Per Share

Dividend15 Feb 2024

Face Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share

Split17 Sept 2023

Dividend - Rs 9.25 Per Share

Dividend16 Aug 2023

Latest News

All news →

JB Chemicals shares unchanged after general updates filing

*JB Chemicals shares unchanged after general updates filing*\nJB Chemicals & Pharmaceuticals informed the NSE about routine corporate updates. No specific financial or operational details were disclosed. The filing appears to be procedural with no immediate market-moving information.\n\n📊 *STOCKS:* JBCHHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate_update

NSE Filing8 Jul
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹904 Cr
▼15.1%
₹1.1K Cr
▼1.8%
₹1.1K Cr
▼0.8%
₹1.1K Cr
▲15.3%
₹949 Cr
▼1.5%
₹963 Cr
▼3.8%
₹1.0K Cr
▼0.3%
₹1.0K Cr
Op. Profit
₹201 Cr
▼32.1%
₹296 Cr
▼4.5%
₹310 Cr
▲3.0%
₹301 Cr
▲33.2%
₹226 Cr
▼11.4%
₹255 Cr
▼5.9%
₹271 Cr
▼3.2%
₹280 Cr
OPM
22.0%
▼21.4%
28.0%
▼3.4%
29.0%
▲3.6%
28.0%
▲16.7%
24.0%
▼7.7%
26.0%
▼3.7%
27.0%
▼3.6%
28.0%
Net Profit
₹101 Cr
▼49.0%
₹198 Cr
▼4.8%
₹208 Cr
▲3.0%
₹202 Cr
▲38.4%
₹146 Cr
▼9.9%
₹162 Cr
▼7.4%
₹175 Cr
▼1.1%
₹177 Cr
EPS (₹)
6.31
▼50.0%
12.63
▼4.8%
13.27
▲2.4%
12.96
▲38.5%
9.36
▼10.4%
10.45
▼7.0%
11.24
▼1.3%
11.39

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹4.1K Cr
▲5.9%
₹3.9K Cr
▲12.5%
₹3.5K Cr
▲10.6%
₹3.1K Cr
▲29.9%
₹2.4K Cr
▲18.6%
₹2.0K Cr
▲15.1%
₹1.8K Cr
▲8.0%
₹1.6K Cr
▲16.7%
₹1.4K Cr
▲4.8%
₹1.3K Cr
Expenses
₹3.0K Cr
▲5.3%
₹2.9K Cr
▲11.6%
₹2.6K Cr
▲5.4%
₹2.5K Cr
▲30.5%
₹1.9K Cr
▲26.9%
₹1.5K Cr
▲6.1%
₹1.4K Cr
▲4.5%
₹1.3K Cr
▲12.3%
₹1.2K Cr
▲7.1%
₹1.1K Cr
Op. Profit
₹1.1K Cr
▲7.3%
₹1.0K Cr
▲15.1%
₹897 Cr
▲28.9%
₹696 Cr
▲28.2%
₹543 Cr
▼3.0%
₹560 Cr
▲48.1%
₹378 Cr
▲23.5%
₹306 Cr
▲40.4%
₹218 Cr
▼6.0%
₹232 Cr
OPM
27.0%
▲3.8%
26.0%
▲0.0%
26.0%
▲18.2%
22.0%
▲0.0%
22.0%
▼18.5%
27.0%
▲28.6%
21.0%
▲10.5%
19.0%
▲26.7%
15.0%
▼11.8%
17.0%
Other Income
₹33 Cr
▼13.2%
₹38 Cr
▲2.7%
₹37 Cr
▲270.0%
₹10 Cr
▼74.4%
₹39 Cr
▼65.2%
₹112 Cr
▲173.2%
₹41 Cr
▲0.0%
₹41 Cr
▲10.8%
₹37 Cr
▼26.0%
₹50 Cr
Interest
₹6 Cr
▼50.0%
₹12 Cr
▼72.7%
₹44 Cr
▲22.2%
₹36 Cr
▲620.0%
₹5 Cr
▼28.6%
₹7 Cr
▲133.3%
₹3 Cr
▼40.0%
₹5 Cr
▲66.7%
₹3 Cr
▼40.0%
₹5 Cr
Depreciation
₹182 Cr
▲6.4%
₹171 Cr
▲23.9%
₹138 Cr
▲21.1%
₹114 Cr
▲56.2%
₹73 Cr
▲5.8%
₹69 Cr
▲4.5%
₹66 Cr
▲17.9%
₹56 Cr
▼1.8%
₹57 Cr
▲21.3%
₹47 Cr
PBT
₹952 Cr
▲7.3%
₹887 Cr
▲18.0%
₹752 Cr
▲35.5%
₹555 Cr
▲9.9%
₹505 Cr
▼15.4%
₹597 Cr
▲71.1%
₹349 Cr
▲21.6%
₹287 Cr
▲47.9%
₹194 Cr
▼15.7%
₹230 Cr
Tax %
26.0%
▲0.0%
26.0%
▲0.0%
26.0%
▲0.0%
26.0%
▲8.3%
24.0%
▼4.0%
25.0%
▲13.6%
22.0%
▼31.3%
32.0%
▲14.3%
28.0%
▲40.0%
20.0%
Net Profit
₹709 Cr
▲7.4%
₹660 Cr
▲19.3%
₹553 Cr
▲34.9%
₹410 Cr
▲6.2%
₹386 Cr
▼14.0%
₹449 Cr
▲65.1%
₹272 Cr
▲40.2%
₹194 Cr
▲39.6%
₹139 Cr
▼24.5%
₹184 Cr
EPS (₹)
44.18
▲4.3%
42.36
▲19.0%
35.61
▲34.5%
26.48
▲6.2%
24.93
▼14.0%
28.98
▲64.7%
17.6
▲45.9%
12.06
▲45.8%
8.27
▼23.8%
10.85
Div Payout
50.0%
▲35.1%
37.0%
▲8.8%
34.0%
▲0.0%
34.0%
▲3.0%
33.0%
▲17.9%
28.0%
▼9.7%
31.0%
▲47.6%
21.0%
▲75.0%
12.0%
▲140.0%
5.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹16 Cr
▲0.0%
₹16 Cr
▲0.0%
₹16 Cr
▲6.7%
₹15 Cr
▲0.0%
₹15 Cr
▲0.0%
₹15 Cr
▲0.0%
₹15 Cr
▼6.3%
₹16 Cr
▼5.9%
₹17 Cr
▲0.0%
₹17 Cr
Reserves
₹4.1K Cr
▲21.2%
₹3.4K Cr
▲17.5%
₹2.9K Cr
▲18.0%
₹2.5K Cr
▲16.3%
₹2.1K Cr
▲18.1%
₹1.8K Cr
▲26.3%
₹1.4K Cr
▼3.0%
₹1.5K Cr
▲2.7%
₹1.4K Cr
▲5.8%
₹1.3K Cr
Borrowings
₹4 Cr
▼85.7%
₹28 Cr
▼92.6%
₹378 Cr
▼33.9%
₹572 Cr
▲940.0%
₹55 Cr
▲22.2%
₹45 Cr
▲55.2%
₹29 Cr
▲11.5%
₹26 Cr
▼10.3%
₹29 Cr
▼40.8%
₹49 Cr
Other Liabilities
₹799 Cr
▼0.6%
₹804 Cr
▲17.0%
₹687 Cr
▲38.8%
₹495 Cr
▲20.1%
₹412 Cr
▲9.6%
₹376 Cr
▲7.7%
₹349 Cr
▲22.0%
₹286 Cr
▼2.7%
₹294 Cr
▲12.2%
₹262 Cr
Total Liabilities
₹5.0K Cr
▲16.3%
₹4.3K Cr
▲6.9%
₹4.0K Cr
▲12.4%
₹3.5K Cr
▲36.4%
₹2.6K Cr
▲16.6%
₹2.2K Cr
▲23.0%
₹1.8K Cr
▲1.2%
₹1.8K Cr
▲1.5%
₹1.8K Cr
▲5.4%
₹1.7K Cr
Assets
Fixed Assets
₹1.9K Cr
▼4.2%
₹2.0K Cr
▼1.8%
₹2.0K Cr
▲5.4%
₹1.9K Cr
▲48.9%
₹1.3K Cr
▲101.4%
₹634 Cr
▼2.6%
₹651 Cr
▲4.8%
₹621 Cr
▼3.0%
₹640 Cr
▼5.7%
₹679 Cr
CWIP
₹74 Cr
▲17.5%
₹63 Cr
▼17.1%
₹76 Cr
▲38.2%
₹55 Cr
▲189.5%
₹19 Cr
▼26.9%
₹26 Cr
▲62.5%
₹16 Cr
▲6.7%
₹15 Cr
▼11.8%
₹17 Cr
▲325.0%
₹4 Cr
Investments
₹765 Cr
▲121.7%
₹345 Cr
▼11.1%
₹388 Cr
▲88.3%
₹206 Cr
▲1484.6%
₹13 Cr
▼98.1%
₹678 Cr
▲68.2%
₹403 Cr
▼11.8%
₹457 Cr
▲5.3%
₹434 Cr
▲5.6%
₹411 Cr
Other Assets
₹2.2K Cr
▲18.4%
₹1.9K Cr
▲24.4%
₹1.5K Cr
▲9.7%
₹1.4K Cr
▲7.1%
₹1.3K Cr
▲44.6%
₹894 Cr
▲20.3%
₹743 Cr
▲6.3%
₹699 Cr
▲3.7%
₹674 Cr
▲16.2%
₹580 Cr
Total Assets
₹5.0K Cr
▲16.3%
₹4.3K Cr
▲6.9%
₹4.0K Cr
▲12.4%
₹3.5K Cr
▲36.4%
₹2.6K Cr
▲16.6%
₹2.2K Cr
▲23.0%
₹1.8K Cr
▲1.2%
₹1.8K Cr
▲1.5%
₹1.8K Cr
▲5.4%
₹1.7K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Operating CF
₹704 Cr
▼22.0%
₹902 Cr
▲12.6%
₹801 Cr
▲28.0%
₹626 Cr
▲268.2%
₹170 Cr
▼46.0%
₹315 Cr
▲14.1%
₹276 Cr
▲42.3%
₹194 Cr
▲57.7%
₹123 Cr
▼38.8%
₹201 Cr
Investing CF
₹-586 Cr
▼98.0%
₹-296 Cr
▲26.7%
₹-404 Cr
▲58.0%
₹-962 Cr
▼48200.0%
₹2 Cr
▲100.9%
₹-231 Cr
▼1062.5%
₹24 Cr
▲185.7%
₹-28 Cr
▼33.3%
₹-21 Cr
▲53.3%
₹-45 Cr
Financing CF
₹-123 Cr
▲78.8%
₹-580 Cr
▼50.6%
₹-385 Cr
▼207.8%
₹357 Cr
▲358.7%
₹-138 Cr
▼58.6%
₹-87 Cr
▲71.6%
₹-306 Cr
▼96.2%
₹-156 Cr
▼160.0%
₹-60 Cr
▲67.4%
₹-184 Cr
Net Cash Flow
₹-5 Cr
▼118.5%
₹27 Cr
▲145.5%
₹11 Cr
▼45.0%
₹20 Cr
▼41.2%
₹34 Cr
▲1233.3%
₹-3 Cr
▲50.0%
₹-6 Cr
▼154.5%
₹11 Cr
▼74.4%
₹43 Cr
▲253.6%
₹-28 Cr
Free Cash Flow
₹623 Cr
▼20.4%
₹783 Cr
▲45.0%
₹540 Cr
▲491.3%
₹-138 Cr
▲73.9%
₹-529 Cr
▼267.9%
₹315 Cr
▲53.7%
₹205 Cr
▲34.0%
₹153 Cr
▲62.8%
₹94 Cr
▲95.8%
₹48 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Debtor Days
69d
▼9.2%
76d
▲5.6%
72d
▲7.5%
67d
▼20.2%
84d
▲20.0%
70d
▼1.4%
71d
▲4.4%
68d
▼12.8%
78d
▲8.3%
72d
Inventory Days
192d
▲30.6%
147d
▼5.2%
155d
▲15.7%
134d
▼24.7%
178d
▼1.7%
181d
▲13.8%
159d
▲6.7%
149d
▲2.8%
145d
▲5.1%
138d
Days Payable
110d
▼3.5%
114d
▲3.6%
110d
▲46.7%
75d
▼22.7%
97d
▲0.0%
97d
▲0.0%
97d
▲34.7%
72d
▼4.0%
75d
▲10.3%
68d
Cash Conv. Cycle
151d
▲38.5%
109d
▼6.8%
117d
▼7.9%
127d
▼22.6%
164d
▲7.2%
153d
▲15.0%
133d
▼8.9%
146d
▼1.4%
148d
▲4.2%
142d
Working Capital Days
126d
▲59.5%
79d
▲43.6%
55d
▼32.1%
81d
▼33.6%
122d
▲34.1%
91d
▲12.3%
81d
▼11.0%
91d
▼2.2%
93d
▲24.0%
75d
ROCE
25.0%
▼3.8%
26.0%
▲4.0%
25.0%
▲13.6%
22.0%
▼4.3%
23.0%
▼30.3%
33.0%
▲43.5%
23.0%
▲27.8%
18.0%
▲63.6%
11.0%
▼21.4%
14.0%

Source: Screener.in · Lower days = better efficiency

About JB Chemicals & Pharmaceuticals Limited

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]

Healthcare · Pharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is JB Chemicals & Pharmaceuticals Limited share price today?▾
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is currently trading at ₹2,416.1 on NSE, up 0.30% as of the last market session. Prices update daily after market close on MarketNetra.
Is JB Chemicals & Pharmaceuticals Limited available in F&O (Futures & Options)?▾
Yes, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is JB Chemicals & Pharmaceuticals Limited 52-week high and low?▾
JB Chemicals & Pharmaceuticals Limited's 52-week high is ₹2,526 and the 52-week low is ₹1,603. The current price of ₹2,416.1 is 4.4% below the 52W high.
What is JB Chemicals & Pharmaceuticals Limited P/E ratio?▾
JB Chemicals & Pharmaceuticals Limited's current P/E ratio is 53.8. This indicates the market is paying ₹53.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade JB Chemicals & Pharmaceuticals Limited options?▾
JB Chemicals & Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade JBCHEPHARM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.